Send feedback

CABP2 p.Arg94Gln

c.281G>A · rs2276118 · VCV506033

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 6 submitters
AlphaMissense
likely benign
0.0783 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 67.7%, eas) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
autosomal recessive nonsyndromic hearing loss 93

Computational evidence

Protein change
AlphaMissense0.0783likely benign
REVEL0.057moderately benign-leaning
SaProtLLR -7.46tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -1.8GERP -1.6
Regional constrainto/e 0.99unconstrained · MANE · 4,184 bp · p 0.9 · regional, not allelic
Overall
CADD14.13PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 67.7% East Asian · 30,354/44,830 alleles
Filtering AF 67.1% ClinGen BA1/BS1 input FAF95, joint · FAF99 66.8%
Overall 54.2% 874,351/1,612,864 alleles · common
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 67.7% 1
East Asiangrpmax 67.7% 1
South Asian 63.5% 2
Amishnot grpmax-eligible 57.2% 2
Middle Eastern 56.6% 2
European (non-Finnish) 56.2% 2
Remaining individualsnot grpmax-eligible 54.4% 2
Finnishnot grpmax-eligible 54.1% 2
Admixed American 38.8% 3
African / African-American 10.3% 10

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CABP2
Protein
p.Arg94Gln
Coding
c.281G>A
MANE Select
NM_016366
dbSNP
rs2276118
Type
single nucleotide variant
Location
chr11:67521123 (GRCh38)
Gene constraint
LOEUF 1.299 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 68.93
Residue 94
the ef-hand 1 domain; a UniProt-annotated variant site (in)
Full CABP2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cabp2-p-arg94gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown